Terms: = Colorectal cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Prognosis
200 results:
1. USP18 promotes colon adenocarcinoma progression via targeting the erk-MNK signaling pathway.
Tang N; Liu X
J Gene Med; 2024 Jul; 26(7):e3709. PubMed ID: 38949077
[TBL] [Abstract] [Full Text] [Related]
2. Regulator of G protein signaling 16 restrains apoptosis in colorectal cancer through disrupting TRAF6-TAB2-TAK1-JNK/p38 MAPK signaling.
Shen H; Yuan J; Tong D; Chen B; Yu E; Chen G; Peng C; Chang W; E J; Cao F
Cell Death Dis; 2024 Jun; 15(6):438. PubMed ID: 38906869
[TBL] [Abstract] [Full Text] [Related]
3. [Retrospective study of role of neoadjuvant rectal scores in evaluating the 10-year disease-free survival of patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy followed by surgery].
Zhang WL; Zhou C; Wang WF; Li WH; He JH; Lu ZH; Wu XJ; Lin JZ; Peng JH
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Jun; 27(6):608-614. PubMed ID: 38901994
[No Abstract] [Full Text] [Related]
4. erk Inhibition as a Promising Therapeutic Strategy for High IL-8-Secreting and Low SPTAN1-Expressing colorectal cancer.
Meier C; La Rocca G; Nawrot V; Fißlthaler B; Overby SJ; Hourfar K; Plotz G; Seidl C; Ziegler P; Wild P; Zeuzem S; Brieger J; Jäger E; Battmann A; Brieger A
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891846
[TBL] [Abstract] [Full Text] [Related]
5. Antitumor activity of dictamnine against colorectal cancer through induction of ferroptosis and inhibition of M2 macrophage polarization via the MAPK signaling.
Zuo X; Lin H; Song Z; Yu B; Zhao C
Arch Biochem Biophys; 2024 Aug; 758():110051. PubMed ID: 38851368
[TBL] [Abstract] [Full Text] [Related]
6. Identification and Validation of SLC9A2 as A Potential Tumor Suppressor in colorectal cancer: Integrating Bioinformatics Analysis with Experimental Confirmation.
Liu YM; Yang TC; Fang XC; Yang LJ; Shi LW; Wang HQ; Dou TT; Shu L; Chen TL; Hu J; Yu XM; Li XF
Curr Med Sci; 2024 Jun; 44(3):529-544. PubMed ID: 38809379
[TBL] [Abstract] [Full Text] [Related]
7. Tenascin C as a novel zinc finger protein 750 target regulating the immunogenicity via DNA damage in lung squamous cell carcinoma.
Xia L; Lin H; Cao H; Lian J
BMC Cancer; 2024 May; 24(1):561. PubMed ID: 38711034
[TBL] [Abstract] [Full Text] [Related]
8. PTPLAD1 Regulates PHB-Raf Interaction to Orchestrate Epithelial-Mesenchymal and Mitofusion-Fission Transitions in colorectal cancer.
Huang ZJ; Li YJ; Yang J; Huang L; Zhao Q; Lu YF; Hu Y; Zhang WX; Liang JZ; Pan J; Pan YL; He QY; Wang Y
Int J Biol Sci; 2024; 20(6):2202-2218. PubMed ID: 38617530
[TBL] [Abstract] [Full Text] [Related]
9. The EIF3H-HAX1 axis increases RAF-MEK-erk signaling activity to promote colorectal cancer progression.
Jin H; Huang X; Pan Q; Ma N; Xie X; Wei Y; Yu F; Wen W; Zhang B; Zhang P; Chen X; Wang J; Liu RY; Lin J; Meng X; Lee MH
Nat Commun; 2024 Mar; 15(1):2551. PubMed ID: 38514606
[TBL] [Abstract] [Full Text] [Related]
10. Role of deubiquitinase JOSD2 in the pathogenesis of esophageal squamous cell carcinoma.
Wang WP; Shi D; Yun D; Hu J; Wang JF; Liu J; Yang YP; Li MR; Wang JF; Kong DL
World J Gastroenterol; 2024 Feb; 30(6):565-578. PubMed ID: 38463028
[TBL] [Abstract] [Full Text] [Related]
11. TIF1γ and SMAD4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis.
Wu Y; Yu B; Ai X; Zhang W; Chen W; Laurence A; Zhang M; Chen Q; Shao Y; Zhang B
Biol Chem; 2024 Apr; 405(4):241-256. PubMed ID: 38270141
[TBL] [Abstract] [Full Text] [Related]
12. Collagen I-induced VCAN/erk signaling and PARP1/ZEB1-mediated metastasis facilitate OSBPL2 defect to promote colorectal cancer progression.
Lin K; Zhao Y; Tang Y; Chen Y; Lin M; He L
Cell Death Dis; 2024 Jan; 15(1):85. PubMed ID: 38267463
[TBL] [Abstract] [Full Text] [Related]
13. KLF7 promotes colon adenocarcinoma progression through the PDGFB signaling pathway.
Zhang Z; Jiang X; Li K; Qiao S; Li M; Mei Y; Ding L; Lv Q; Ding Y; Zhao Y; Lv G; Tan G; Yang H; Li G; Gao X; Liu M
Int J Biol Sci; 2024; 20(1):387-402. PubMed ID: 38164176
[TBL] [Abstract] [Full Text] [Related]
14. Transcriptomic and genomic profiling of multiple primary colorectal cancers reveals intratumor heterogeneity and a distinct immune microenvironment.
Li Y; Li C; Wang Q; Ye YJ; Jiang KW
Int Immunopharmacol; 2024 Jan; 126():111276. PubMed ID: 38016348
[TBL] [Abstract] [Full Text] [Related]
15. A pan-cancer analysis of the MAPK family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
Qin YY; Yang Y; Ren YH; Gao F; Wang MJ; Li G; Liu YX; Fan L
Medicine (Baltimore); 2023 Nov; 102(45):e35829. PubMed ID: 37960824
[TBL] [Abstract] [Full Text] [Related]
16. Gab2 promotes the growth of colorectal cancer by regulating the M2 polarization of tumor‑associated macrophages.
Gao X; Long R; Qin M; Zhu W; Wei L; Dong P; Chen J; Luo J; Feng J
Int J Mol Med; 2024 Jan; 53(1):. PubMed ID: 37937666
[TBL] [Abstract] [Full Text] [Related]
17. The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas.
Sánchez-Tilló E; Pedrosa L; Vila I; Chen Y; Győrffy B; Sánchez-Moral L; Siles L; Lozano JJ; Esteve-Codina A; Darling DS; Cuatrecasas M; Castells A; Maurel J; Postigo A
JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37870961
[TBL] [Abstract] [Full Text] [Related]
18. Cholinergic signaling influences the expression of immune checkpoint inhibitors, PD-L1 and PD-L2, and tumor hallmarks in human colorectal cancer tissues and cell lines.
Kuol N; Godlewski J; Kmiec Z; Vogrin S; Fraser S; Apostolopoulos V; Nurgali K
BMC Cancer; 2023 Oct; 23(1):971. PubMed ID: 37828429
[TBL] [Abstract] [Full Text] [Related]
19. ELK4 Promotes colorectal cancer Progression by Activating the Neoangiogenic Factor LRG1 in a Noncanonical SP1/3-Dependent Manner.
Zhu Z; Guo Y; Liu Y; Ding R; Huang Z; Yu W; Cui L; Du P; Goel A; Liu CY
Adv Sci (Weinh); 2023 Nov; 10(32):e2303378. PubMed ID: 37786278
[TBL] [Abstract] [Full Text] [Related]
20. Tetraspanin 1 regulates papillary thyroid tumor growth and metastasis through c-Myc-mediated glycolysis.
Han J; Xie C; Liu B; Wang Y; Pang R; Bi W; Sheng R; He G; Kong L; Yu J; Ding Z; Chen L; Jia J; Zhang J; Nie C
Cancer Sci; 2023 Dec; 114(12):4535-4547. PubMed ID: 37750019
[TBL] [Abstract] [Full Text] [Related]
[Next]
